Parexel appoints Gwyn Bebb to lead oncology clinical development
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
The market capitalization of the company stood at Rs. 7,000 crore +
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
The partnership acknowledges the increasing mental health challenges faced by students in today's society
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Subscribe To Our Newsletter & Stay Updated